Page 29 - Forbes - Asia (April 2019)

Health Care & Science

Akhila Adabala, 29 India Aayush Rai, 29 India
Cofounder, Praktice.ai CEO, Inito
Tamana Asey, 26 Afghanistan Kuldeep Singh Rajput, 27
Program Director, Afghanistan Singapore
Fornsic Science Organization Founder, Biofourmis
Bian Lin, 29 China Ren Xiang, 28 China
Assistant Professor, Assistant Professor,
Cornell University University of Southern California
Cao Yuan, 22 China Subhrajit Roy, 29 Australia
PhD. candidate, MIT Research Scientist, IBM Research
Gong Enhao, 28 China Nitin Gandhi, 28; Jatin Sharma, 29
Founder, Subtle Medical India
CEO, COO, Shapecrunch
Praveen Gorakavi, 29 India
Partner, The Phi Factory Roopam Sharma, 23 India
Cofounder, Eyeluminati
Manuri Gunawardena, 25 Australia
Founder, HealthMatch Gourish Singla, 26 India
Founder, Project Shivom
Nitesh Jangir, 29 India
Cofounder, Coeo Labs Kalyan Sivasailam, 25 India
CEO, 5C Network
Yei Hwan Jung, 29 South Korea
Postdoctoral Fellow, Tiffany Robyn Soetikno, 25
Sungkyunkwan University Indonesia
Founder, PT Global Urban Esensial
Michiaki Kamo, 24 Japan
Founder, POL Arjun Vaidya, 27 India
CEO, Dr. Vaidya’s (Herbolab India)
Laila Kasuri, 29 Pakistan
Water Analyst, Global Green Roman Vernidub, 29 South Korea
Growth Institute Founder, Koru Pharmaceuticals
Do Hee Keum, 27 South Korea Yap Hong Kai, 27 Singapore
CEO, BUBBLER Cofounder, Roceso Technologies
Liang Lyu, 28 China Zhao Qiang, 28 China
Founder, SonmolTech CEO, Pearl Care Clinic
Yukiko Ogawa, 28 Japan
Researcher, National Institute JUDGES
for Materials Science Meena Ganesh, India
Cofounder and CEO,
Yuki Okoda, 24 Japan Portea Medical
Student, The University of Tokyo
Snehal Patel, Singapore
Gwanho Yoon, 29; Dasol Lee, 28
South Korea Cofounder and CEO, MyDoc
Ph.D candidates, Pohang University Sonny Vu, U.S.
of Science and Technology President and CTO,
Connected Devices-Fossil Group
Sivareena Sarika, 27; Subhadeep
Mondal, 28 India
Cofounders, PregBuddy
Technologies

Manuri

Gunawardena, 25

FOUNDER, HEALTHMATCH AUSTRALIA
As a medical student at the University of New South Wales, Manuri
Gunawardena learned first-hand the difficulty of finding patients to join in
trials for potentially lifesaving treatments. She also noticed there was no
convenient way for patients to search for alternative treatments for their
conditions. So she started HealthMatch in 2017 to solve these problems.
Sydney-based HealthMatch applies machine learning to clinical data to
help researchers and pharmaceutical companies find patients suitable for
their studies—and vice versa. “We are automating access to clinical trials
globally and dramatically improving the future of healthcare by lowering
JING WEI (STUDIO W) FOR FORBES ASIA to raise at least $10 million later this year. HealthMatch charges research
barriers to research and development,” says Gunawardena.
HealthMatch has raised $1.3 million from investors so far, and plans

institutions and drug companies a fee to use its platform and for every
patient they recruit through HealthMatch for clinical studies. Patients don’t
have to pay to use the platform.
The company is projected to generate $5 million in sales next year,
primarily from clinical trials with two Swiss pharmaceutical giants. “Being
under 30 has meant I have an ability to embrace technology and use it in
new ways,” says Gunawardena. —Rana Wehbe

APRIL 2019 FORBES ASIA | 25